Genetic Engineering & Biotechnology News
Published 21 times a year, GEN’s unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness.
Pubsliher:
Mary Ann Liebert, Inc.
HOME | Category: Biotechnology & Pharmaceuticals. | RSS 2.0 feed. | Trackback URI
